Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Flow cytometry is increasingly being used in the biopharma and healthcare sectors
May 6, 2015
By: Mark Edinger
Quintiles
Flow cytometry, the laser-based, biophysical technology employed in cell counting, cell sorting, biomarker detection, and protein engineering, is finding increasing applications in the biopharma and healthcare sectors. These include selecting an appropriate therapy, measuring therapeutic responses, evaluating predictive or prognostic biomarkers, and developing assays to aid in diagnosis. Historically, however, the utility of flow cytometry has been limited by the challenge of standardizing instruments across facilities, companies and geographies. This article provides information for pharmaceutical researchers and flow core staff scientists on a new method of quantitative instrument standardization and set-up using stable, custom-manufactured fluorescent control beads. The use of such beads allows for greater consistency of intra- and inter-platform standardized setup, and provides a satisfactory basis for quantitative instrument standardization. This new approach allows comparable quantitative results to be generated by multiple flow cytometers at the same or different sites. Topics covered in this article include how to perform quantitative instrument setup and how to address problems that may be encountered when performing quantitative flow cytometry. The new method of intra and inter laboratory standardization of flow cytometry instruments allows instruments to produce data that shows very little variation from instrument to instrument for the same assays and sample types. The method is based on the use of BD Cytometer Setup and Tracking (CS&T) beads and custom-manufactured BD FC Beads. BD CS&T beads are comprised of three separate beads that are hard-dyed with varying amounts of fluorescent molecules that mimic fluorochromes that are excited by laser wavelengths of 355, 375, 445, 488, 532, 561, 633, 635, 640 nM. The brightest of the three beads was used originally used for the purposes of standardization, as it exhibited the least intrinsic fluorescence. Bright CS&T Bead Targets were set in worksheets that could be moved between instruments, allowing settings to be created and stored. These stored settings were applications settings that updated daily when the CS&T beads were run to cancel out day-to-day variations within individual instruments. CS&T Bead Standardization Protocol Instrument characterization data derived from setting baseline targets for each detector with the CS&T beads yields information on the electronic noise (SDen) of each detector, and the maximum linearity of each detector, known as the linearity max channel. This information is used to optimize the dynamic range of each detector. The SDen of each detector is multiplied by 2.5 to yield a standard deviation (SD) value to which unstained lymphocytes can be adjusted so that the contribution of electronic noise to the SD of the negative population is less than 10%. Lymphocytes stained with a marker that exhibits the highest fluorescent intensity for that detector are run to adjust the positive staining population to below the linearity max channel value for that detector. The resulting photomultiplier voltages (PMTV) are then saved as Application Settings in BD FACSDiVa software, and the CS&T bright bead median fluorescence intensity (MFI) values were saved as target values. As a result, the same settings can be reproduced on any other instrument that needs to be standardized. Sample data are shown in Figure 1. Problems with Quantitative Flow Assays Problems were encountered during the transfer of quantitative flow cytometry assays across multiple BD FACSCanto II instruments that had been standardized using CS&T beads. A variation of more than 20% in the mean fluorescent index for fluorochrome-labeled molecules of equivalent soluble fluorochrome (MESF) calibration beads was observed for instruments that had been standardized using CS&T beads. This problem was the most severe for the fluorescein isothiocyanate (FITC) detector and made this detector unusable for quantitative work. The variation between instruments was much less in the phycoerythrin (PE) and allophycocyanin (APC) detectors with variation ranging between 2% and 11% for the PE detector and 3.5% and 9.2% for the APC detector. These observable differences in MFI were attributed to:
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !